Project Professor Yoshito Terai of the Kobe University Graduate School of Medicine Department of Obstetrics and Gynecology performed the world's first surgery for endometrial cancer using the hinotori surgical robot system, a surgical assistance robot made in Japan.
Robotic-assisted surgery is performed using a four-armed robot equipped with surgical instruments and an endoscope. Surgery can be performed by manipulating the arm.Since the robot arm can enter areas that cannot be reached by human hands, precise surgical operations are possible. It is said that
On the other hand, da Vinci®, which was developed in the United States, holds the majority of the global market share for surgical assistance robots, and today we have no choice but to rely on imported equipment.Therefore, the development of a domestic surgical support robot has been expected.
The hinotori surgical robot system, developed by Kobe University and Medicaroid Co., Ltd., features a more compact and functional robot arm than da Vinci®, an ergonomically designed operating terminal, and high-definition 3D images. Pharmaceutical approval was obtained in August 2020, insurance coverage in the urology field was received in September, and the first robotic surgery (prostate cancer) using the same system was performed at Kobe University in December of the same year.
Following this, from December 2022, insurance coverage was expanded to include gynecology and gastrointestinal surgery, and this time, the world's first endometrial cancer surgery using the hinotori surgical robot system was performed at Kobe University. I smiled.
In the world of robot-assisted surgery, which used to be dominated by imported equipment, it is highly expected that robotic surgery by hinotori will spread in the future.
